David Baanstra
Impact in
- Internal Medicine top 0.1%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Arrhythmias and Treatments
Papers in
-
- Diabetes Treatment and Management 4
-
- Atrial Fibrillation Management and Outcomes 3
- Co-authors
- Sam Schulman (5 shared papers)Henry Eriksson (5 shared papers)Ajay K. Kakkar (5 shared papers)Samuel Z. Goldhaber (5 shared papers)Clive Kearon (5 shared papers)Sebastian Schellong (4 shared papers)Patrick Mismetti (2 shared papers)Janet Schnee (2 shared papers)
- Journals
- Blood (2 papers)JAMA (2 papers)New England Journal of Medicine (2 papers)Circulation (1 paper)Cardiovascular Diabetology (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
David Baanstra
9 papers receiving 4.0k citations
David Baanstra's Hit Papers
Peers
Comparison fields: 5 of 78
- Internal Medicine 2.0k
- Cardiology and Cardiovascular Medicine 2.1k
- Endocrinology, Diabetes and Metabolism 1.1k
- Hematology 363
- Emergency Medical Services 153
Countries citing papers authored by David Baanstra
This map shows the geographic impact of David Baanstra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Baanstra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Baanstra more than expected).
Fields of papers citing papers by David Baanstra
This network shows the impact of papers produced by David Baanstra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Baanstra. The network helps show where David Baanstra may publish in the future.
Co-authors
The 25 scholars most cited alongside David Baanstra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism Hit paper breakdown → | 2009 | 1948 |
| 2 | Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk Hit paper breakdown → | 2018 | 794 |
| 3 | Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism Hit paper breakdown → | 2013 | 743 |
| 4 | Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes Hit paper breakdown → | 2019 | 422 |
| 5 | 2019 | 116 | |
| 6 | 2018 | 59 | |
| 7 | 2012 | 24 | |
| 8 | 2013 | 21 | |
| 9 | 2009 | 4 |
About David Baanstra
David Baanstra is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Internal Medicine, Epidemiology and Pharmacology, having authored 9 papers that have together received 4.1k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (4 papers), Atrial Fibrillation Management and Outcomes (3 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Pharmaceutical industry and healthcare (1 paper) and Acute Ischemic Stroke Management (1 paper). The work is most often cited by research in Internal Medicine (2.0k citations), Cardiology and Cardiovascular Medicine (2.1k citations), Endocrinology, Diabetes and Metabolism (1.1k citations), Hematology (363 citations) and Emergency Medical Services (153 citations). David Baanstra has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Sam Schulman, Henry Eriksson, Ajay K. Kakkar, Samuel Z. Goldhaber, Clive Kearon, Sebastian Schellong, Patrick Mismetti, Janet Schnee, Jeffrey Friedman and Julio Rosenstock. Their work appears in journals such as Blood, JAMA, New England Journal of Medicine, Circulation and Cardiovascular Diabetology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.